$76.570
-0.023 (-0.03%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
BBIO Prediction & Forecast by Similar Chart Analysis
Alphio's BBIO stock price prediction model matches the current BridgeBio Pharma, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $76.41 (-0.21%). The 1-week path is $76.87 (+0.39%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy BridgeBio Pharma, Inc. Stock?
BridgeBio Pharma Inc is currently a hold rather than a buy due to its low RSI of 18.981, indicating it is oversold, and a significant 53.20% increase over the past year, suggesting strong historical performance. However, the recent 6.01% decline over the last five days and ongoing net losses, with a net income of -152216000 USD in Q2 2026, raise concerns about short-term stability. The main risk is the company's negative net margin of -63.97% in Q2 2026, which indicates ongoing financial struggles despite positive revenue growth.
BBIO stock price ended at $76.57 on Tuesday, after losing -0.03%
BridgeBio Pharma, Inc. (BBIO) last closed at $76.57, losing -0.03%. These facts feed the 1-day and 1-week BBIO price prediction above.
Forecast Drivers
BridgeBio Pharma, Inc. (BBIO) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches BBIO, ranked by similarity.
Seasonality analysis for BBIO
Historically the probability of a positive September return for BBIO is 50.00%. August offers the highest probability of a positive month at 62.50%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for BBIO
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Sep 2026 | $54.60 | $57.13 | $57.62 | -25.39% |
| Oct 2026 | $42.99 | $49.52 | $49.80 | -35.33% |
| Nov 2026 | $55.17 | $56.66 | $60.27 | -26.00% |
| Dec 2026 | $54.39 | $62.38 | $75.53 | -18.53% |
In 2026, BridgeBio Pharma, Inc. (BBIO) is projected to range from $42.99 to $75.53.
BridgeBio Pharma, Inc. 2026 monthly forecast
In Sep 2026, BridgeBio Pharma, Inc. is projected to average $57.13, with a low of $54.60 and high of $57.62.
In Oct 2026, BridgeBio Pharma, Inc. is projected to average $49.52, with a low of $42.99 and high of $49.80.
In Nov 2026, BridgeBio Pharma, Inc. is projected to average $56.66, with a low of $55.17 and high of $60.27.
In Dec 2026, BridgeBio Pharma, Inc. is projected to average $62.38, with a low of $54.39 and high of $75.53.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.